Example: tourism industry
The global burden of cerebrovascular disease
The 1990 Global Burden of Disease (GBD) study provided the first global estimate on the burden of 135 diseases, and cerebrovascular diseases ranked as the second leading cause of death after ischemic heart disease 1. The best possible sources of information on the different disease were used, and for countries or regions where no data were
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
healthy living Master Plan - Ministry of Health
www.moh.gov.sg3 Disease burden is the impact of a health problem measured in terms of financial cost, ill health and preventable death. It can be quantified in terms of quality-adjusted life years (QALYs) or disabilityadjusted life years (DALYs), both of which quantify the number of years lost due to disease. 4 Singapore Burden of Diseases Study, 2010.
SINGAPORE BURDEN OF DISEASE STUDY SINGAPORE …
www.moh.gov.sgThe inaugural Singapore Burden of Disease (SBoD) 2004 Study, which aimed to provide a comprehensive assessment of the health status of Singapore resident population was completed in 2008. The single indicator known as the disability-adjusted life years (DALY) was used to measure burden of disease in the population in the SBoD Study. It is a health
The Role of Social Media during the COVID-19 Pandemic
annals.edu.sginefficient and a burden that takes away time and . Fig. 1. An Instagram post showing appreciation to unsung heroes labouring during the COVID-19 pandemic. (Reference: Nusmedicine. The COVID-19 Chronicles. Instagram; 2020) Fig. 2. Students from Duke-NUS Medical School encouraging the healthcare staff on the frontlines of COVID-19 via a video posted
Pharmacovigilance and Risk Management - Elsevier
www.elsevier.comyICON Clinical Research Pte Ltd/Asia Pacific, Singapore CHAPTER OUTLINE Definition of Pharmacovigilance and Risk Management 142 The Importance of Implementing a Systematic Pharmacovigilance Approach in Global Clinical Trials 142 Operational Overview of Pharmacovigilance 143 Components and Capabilities of a Complete Pharmacovigilance …